Santa Barbara-based inbound call technology firm Invoca has added Salesforce.com to its investor roster and released a new voice intelligence technology to help its customers decode incoming calls. Invoca’s software lets marketers generate unique phone numbers for campaigns and then route and track the calls and sales that result. The company has raised more than Read More →
Auto industry legend J.D. “Dave” Power III, co-founder of J.D. Power & Associates, will become the ninth member of the Pacific Coast Business Times’ regional Business Hall of Fame. Power and the rankings produced by the firm he founded, Westlake Village-based J.D. Power & Associates, have been hugely influential on the auto industry. Power’s pioneering Read More →
The Starbucks-anchored retail center at 1046 Coast Village Road in Montecito has been sold to a local couple for $14.5 million. Montecito residents Deborah and James Longo purchased the 13,800-square-foot property in an off-market deal, according to Radius Commercial Real Estate & Investments. Along with the coffee shop, the other long-term tenants at the Read More →
Carpinteria-based online learning company Lynda.com has purchased Compilr, a Canadian firm that runs a cloud-based platform for programmers to write and test code. Terms of the deal were not announced, but TechCrunch said people close to the transaction valued it at around $20 million. Last year, Lynda.com raised $103 million in its first round of Read More →
San Luis Obispo-based Hortau, a company that makes cloud-based irrigation control systems for farmers, has raised $3.5 million in financing from Avrio Capital.
A Ventura-based surgical products company won a $30 million jury verdict today in a trademark infringement lawsuit. The verdict is the second attempt at a decision for Neurovision Medical Products, which sued San Diego-based medical device firm NuVasive in 2009. Neurovision alleged that NuVasive willfully infringed on the Ventura company’s “Neurovision” trademark. A jury in Read More →
Amgen will pay $290 million to end its collaboration with British drugmaker GlaxoSmithKline to commercialize the osteoporosis drug denosumab in certain markets outside the U.S.